Abbott receives FDA approval for heart valve leak treatment device
Abbott says the FDA approved its first device to treat leaks after heart valve replacement.
Related stories
Google quarterly revenue and profit miss expectations
Google reported quarterly revenue and profit below expectations.
M impact | EQUITY | Oct 29, 2026, 09:21 AM UTC
Amazon cuts about 250 jobs in Devices and Services
Amazon is cutting about 250 positions in its Devices and Services division.
L impact | EQUITY | Oct 29, 2026, 09:21 AM UTC
Anthropic Plans to Open IPO Subscription to UK and European Retail Investors
Anthropic plans to allow retail investors in the UK and Europe to subscribe to its IPO.
L impact | EQUITY | Oct 29, 2026, 09:21 AM UTC
Wilmar Agrees to Independent Probe Into Possible Indonesia Fire Links
Wilmar agreed to an independent investigation into a possible connection with fires in Indonesia.
L impact | EQUITY | Oct 29, 2026, 09:21 AM UTC
MI Technovation Reports Q3 Revenue of 256 Million RGT
M impact | EQUITY | Oct 29, 2026, 09:21 AM UTC
Western Region Gold Q3 Net Profit Rises 246.4% Year Over Year
M impact | EQUITY | Oct 29, 2026, 09:21 AM UTC